GXYLT2 and bladder transitional cell carcinoma: The results showed that high GXYLT2 indicated poor overall survival of patients with BLCA in all three databases (Figures 2(a)–2(c)), which corresponded with the differential expression of GXYLT2 in various stages of BLCA.